Stanford Medicine researchers have permanently cured Type 1 diabetes in mice using a method they call an "immune system reset" — a combined blood stem cell and islet cell transplant that creates a hybrid immune system tolerant of the donor's insulin-producing cells. [1]

The results exceeded expectations. In one group, all 19 pre-diabetic mice remained diabetes-free after treatment. In another, all 9 mice with established diabetes were fully cured. Crucially, none required the chronic immune suppression drugs that have limited previous transplant approaches. [2]

The method works by transplanting blood stem cells that partially replace the recipient's immune system, creating what researchers describe as a "blended" or chimeric immune system. This chimeric system accepts islet cell transplants from the same donor without attacking them — solving the rejection problem that has stymied diabetes cure research for decades. [3]

Live Science reported the approach could be applicable to other autoimmune conditions, not just diabetes, since the underlying mechanism is immune tolerance rather than disease-specific therapy. [4] Human trials are not yet scheduled, but the Stanford team has described the mouse results as sufficient to pursue clinical testing.

Every year brings a new mouse cure for diabetes. This one is different because it bypasses immune suppression entirely. Whether that difference survives the leap to human biology is the only question that matters.

-- KENJI NAKAMURA, Tokyo.